Medicine and Dentistry
Tumor Cell Line
100%
Methylation
100%
DNA Methylation
100%
Radiosensitivity
75%
Malignant Neoplasm
50%
Tumor Cell
50%
Ionizing Radiation
50%
Trichostatin A
50%
Ataxia Telangiectasia
50%
P16
50%
Decitabine
50%
Gene Expression
50%
Gene Promoter
50%
MTT Assay
25%
Programmed Cell Death
25%
In Vitro
25%
Mitosis
25%
Clonogenic Assay
25%
Radiation Response
25%
Cell Damage
25%
Reversed Phase High Performance Liquid Chromatography
25%
Cell Cycle M Phase
25%
Luciferase Assay
25%
Cyclin Dependent Kinase Inhibitor 2A
25%
DNA Strand
25%
Resistant Cell Line
25%
Cell Death
25%
Cell Line
25%
Demethylation
25%
Biochemistry, Genetics and Molecular Biology
Methylation
100%
DNA Methylation
100%
Radiosensitivity
75%
Gene Promoter
50%
Gene Expression
50%
Ataxia Telangiectasia Mutated
50%
Trichostatin A
50%
P16
50%
Mutated Genes
50%
Decitabine
50%
Transcription
25%
Epigenetics
25%
Reverse Phase High Performance Liquid Chromatography
25%
Demethylation
25%
Demethylating Agent
25%
DNA Strand
25%
Cell Cycle M Phase
25%
Mitosis
25%
Clonogenic Assay
25%
Cell Death
25%
Cyclin-Dependent Kinase
25%
MTT Assay
25%
Cell Damage
25%
Luciferase
25%
INIS
humans
100%
tumor cells
100%
sensitivity
100%
radiations
100%
methylation
100%
genes
55%
dna
55%
cancer
22%
promoters
22%
apoptosis
22%
ionizing radiations
22%
radiosensitivity
22%
deoxycytidine
22%
doses
11%
in vitro
11%
damage
11%
therapy
11%
transcription
11%
kinases
11%
information
11%
irradiation
11%
high-performance liquid chromatography
11%
time dependence
11%
chromatin
11%
luciferase
11%
radiation effects
11%
strand breaks
11%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
100%
Malignant Neoplasm
40%
Ionizing Radiation
40%
Trichostatin A
40%
Ataxia Telangiectasia
40%
Decitabine
40%
Reverse Phase High Performance Liquid Chromatography
20%
Radiation Effect
20%
Cyclin Dependent Kinase Inhibitor 2A
20%
Luciferase
20%